Compounds > tyrosine

tyrosine and Gastrointestinal Stromal Tumors

tyrosine has been researched along with Gastrointestinal Stromal Tumors in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
de Haan, JJ; IJzerman, NS; Mathijssen, RHJ; Reyners, AKL; Steeghs, N; van Elst, JM1
Dragomir, C; Ghirlea, O; Olariu, S; Parau, A; Ratiu, S1
Abe, R; Esumi, H; Horikawa, K; Murata, T; Nishida, T; Obata, Y; Shiina, I; Suzuki, K; Takahashi, T; Tasaki, Y; Yonekura, K1
Ako, M; Doki, Y; Fujimoto, M; Ikezoe, T; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Naka, T; Nakajima, K; Nakatsuka, R; Nishida, T; Serada, S; Shimada, K; Taguchi, T; Takahashi, T; Takiguchi, S; Yamasaki, M; Yokoyama, A1
Corless, CL; Heinrich, MC; Keegan, D; Maguire, D; O'Riain, C; Sheahan, K; Vioreanu, M1
Catley, L; Fabbro, D; Griffin, JD; Hall-Meyers, E; Jiang, J; Kung, AL; Manley, PW; Moreno, D; Podar, K; Ray, A; Weisberg, E; Wright, RD1
Cohen, PS; Demetri, GD; Fletcher, CD; Fletcher, JA; Ou, WB; Zhu, MJ1

Other Studies

7 other study(ies) available for tyrosine and Gastrointestinal Stromal Tumors

ArticleYear
Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022, Volume: 30, Issue:3

    Topics: Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Protein Kinase Inhibitors; Quality of Life; Smell; Taste; Tyrosine

2022
Gastrointestinal stromal tumor. A case report with over 5 years follow-up.
    Annali italiani di chirurgia, 2022, Jul-18, Volume: 11

    Topics: Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Neoplasm Recurrence, Local; Prognosis; Tyrosine

2022
Oncogenic Kit signalling on the Golgi is suppressed by blocking secretory trafficking with M-COPA in gastrointestinal stromal tumours.
    Cancer letters, 2018, 02-28, Volume: 415

    Topics: Cell Line, Tumor; Endoplasmic Reticulum; Gastrointestinal Stromal Tumors; Golgi Apparatus; Humans; Microscopy, Confocal; Mutation; Naphthols; Oncogene Proteins; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-kit; Pyridines; Signal Transduction; Tyrosine

2018
New findings of kinase switching in gastrointestinal stromal tumor under imatinib using phosphoproteomic analysis.
    International journal of cancer, 2013, Dec-01, Volume: 133, Issue:11

    Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Focal Adhesion Protein-Tyrosine Kinases; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phosphoproteins; Phosphorylation; Phosphotransferases; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Tyrosine

2013
Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features.
    The American journal of surgical pathology, 2005, Volume: 29, Issue:12

    Topics: Adult; Alleles; Amino Acid Substitution; Coiled Bodies; Colectomy; DNA Mutational Analysis; DNA, Neoplasm; Exons; Gastrectomy; Gastrointestinal Stromal Tumors; Germ-Line Mutation; Hepatectomy; Heterozygote; Histocytochemistry; Homozygote; Humans; Hyperplasia; Immunohistochemistry; Laparotomy; Liver; Male; Neoplasm Metastasis; Pancreaticoduodenectomy; Pedigree; Point Mutation; Proto-Oncogene Proteins c-kit; Sequence Analysis, DNA; Tomography, X-Ray Computed; Tumor Burden; Tyrosine

2005
Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.
    Gastroenterology, 2006, Volume: 131, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Imatinib Mesylate; Male; Mice; Mice, Nude; Phosphorylation; Piperazines; Point Mutation; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Staurosporine; Tyrosine; Xenograft Model Antitumor Assays

2006
KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
    Oncogene, 2007, Sep-27, Volume: 26, Issue:44

    Topics: Antineoplastic Agents; Blotting, Western; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Immunoprecipitation; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-kit; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; RNA, Small Interfering; STAT1 Transcription Factor; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine

2007